You are on page 1of 50

2010-20

A Decade of
Triumphs and Trials

Gautam Duggad
Gautam.Duggad@motilaloswal.com
Deven Mistry
Deven@motilaloswal.com
June 2020
JANUARY 2021
2010-20: A Decade of
Triumphs and Trials
 As we step into CY21, this edition of our Strategy report looks at the decade gone by from various lenses –
markets, economy, stocks, politics and several key events which unfolded and defined the 2020’s.
 As the popular saying goes, “One overestimates the change that can occur in the short term and
underestimates the change that will occur in the long term.” A decade is a fairly long time in the market to
reminisce the ‘change’ from many angles.
 While the stock market provided modest CAGR returns, the decade has seen many triumphs and tribulations.
After almost three decades of coalition governments, the country saw its first decisive mandate for a single
party government in 2014. This was repeated in 2019 with an even greater decisive mandate, a first in five
decades that a single party majority government was re-elected to power. This brought several big ticket and
game-changing reforms to the fore over the last six years.
 Cliché as it may sound, global and domestic equity markets witnessed elevated disruption and consequent
volatility in the last decade. This ensured sharp divergences in returns, not just across sectors, but even
within the sector. The decade witnessed emergence of several Technology companies overtake companies
that have been in existence for multiple decades. Innovation, startups, disruption became the buzzwords as
incumbent legacy business models were disrupted by new age entrepreneurs. There have been several macro
crises as well along the way (taper tantrum, currency meltdown, crude spike, COVID-19). On the macro front,
if the 2000-10’s decade was known for investment, capital formation, and capex cycle, the 2010-20 decade
would be known for deleveraging and the absence of private capex.
 Corporate earnings – the fuel for the market’s upwards journey – were muted in the decade gone by. Hope
for an earnings revival, as ever, remains intact as India emerges out of the COVID-19 crisis.
 The last decade also saw near historical low interest rates, both in India and globally, which would have a
defining impact on consumption, growth outlook, valuation of asset classes, and multiple other aspects.

A Decade of Triumphs and Trials | January 2021 2 June 2020


Narendra Modi
wins historic
India wins the elections
ICC World Cup
2014
ISRO made history when
India became the first
2014 country in the world to reach
2011 Mars in its maiden attempt

Reliance Jio’s
commercial launch

Important events
2016 during the decade 2015
The frenzy over a

gone by Federal Reserve rate


hike had an alarming
effect on markets

2010-
2016 2020

Oil prices touched


Demonetization and 2016 USD100/bbl and turned
digitalization of the negative both in the
Indian economy decade gone by
Military aggression – India
avenged the Uri attack

A Decade of Triumphs and Trials | January 2021 3 June 2020


GST: Historic rollout of the
single tax regime

2017

2018 US-China trade war

2020

Mr Aditya Puri, MD of HDFC Bank,


retired after a very successful 25
years of leadership with the bank
Important events
during the decade 2018

gone by ILFS crisis roiled the


debt market

2020

2019
A year when markets saw
both Bull and Bear cycles

2020 Pulwama attack and


Balakot air strike
A pandemic year

A Decade of Triumphs and Trials | January 2021 4 June 2020


Looking back: A decade in the market
Nifty delivers eight years of positive return

Sources of exhibits in this report include Bloomberg, SEBI, NSE, Capitaline, companies, RBI, CEIC and MOFSL’s database

A Decade of Triumphs and Trials | January 2021 5 June 2020


Global equities: The US was the best performing market in the decade gone by
Performance of world equity indices – in local currency (%) – India Performance of world equity indices – in USD (%) – Taiwan and South Korea
delivered the third highest return among key global markets overtook India in USD terms

CY10-20 (%, CAGR) CY10-20 (%, CAGR)

US - S&P 500 12 US - S&P 500 12

Japan 10 Japan 8

India - Nifty 9 Taiwan 5

Brazil 6 South Korea 4

Taiwan 5 India - Nifty 3

South Korea 3 MSCI EM 1

Russia MICEX 3 UK 0

MSCI EM 1 China (HSCEI) -2

UK 1 Russia MICEX -6

China (HSCEI) -2 Brazil -6

A Decade of Triumphs and Trials | January 2021 6 June 2020


India’s global rank remains stable
Global ranking on a market capitalization basis – India v/s others
M-cap rank M-cap CY20 CAGR (%) Change
Country CY10 CY15 CY20 (USD t) Change (%) 5 year 10 year in rank
United States 1 1 1 42.6 24 13 11 0

China 5 2 2 10.9 49 9 13 3

Japan 2 3 3 6.8 8 6 5 -1

Hong Kong 4 4 4 6.5 18 10 7 0

United Kingdom 3 5 5 3.3 -6 -1 0 -2

France 7 6 6 2.9 8 9 5 1

Canada 6 8 7 2.6 11 10 2 -1

India 8 10 8 2.5 17 11 4 0
Germany 9 7 9 2.5 10 6 5 0

South Korea 13 11 10 2.1 46 12 7 3

Switzerland 12 9 11 2.0 8 6 5 1

Taiwan 15 13 12 1.8 33 16 7 3

Australia 10 12 13 1.6 18 9 1 -3

Sweden 18 14 14 1.1 32 11 7 4

Netherlands 25 20 15 1.0 33 20 12 10

A Decade of Triumphs and Trials | January 2021 7 June 2020


World m-cap crosses USD100t
Global m-cap has doubled in the decade gone by

World m-cap (USD t)

103
87
81
66 70
62 65 64
52 52
46

CY10 CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20

India’s share in global m-cap at its historical average

India's Contribution to World Mcap (%)


3.5
3.1
3.0
Average: 2.4%
2.5 2.4

2.0

1.6
1.5
Nov-11

Nov-14
Sep-12

Feb-13

Jul-20
Dec-10

Dec-17

Dec-20
Jun-11

Jun-14

Jun-17
Jan-14

Mar-16
Oct-15

Jan-17

Mar-19
Oct-18

Jan-20
May-18
Apr-12

Apr-15
Aug-13

Aug-16

Aug-19
A Decade of Triumphs and Trials | January 2021 8 June 2020
Indian equities outperform other asset classes
CY10-20 returns for various asset classes (%, CAGR)

10.2
9.3
7.6 7.6
5.8

2.9

India Treasury Bill Yield Bank FD 10 Year G Sec % Gold $ Gold INR Equities (Nifty TR)
12 Month

Note: Yield, bank FD and G-Sec returns are average for the decade

Nifty delivered eight years of positive return in the decade gone by; CY11 and CY15 were exceptions

18 -25 28 7 31 -4 3 29 3 12 15
23 -37 24 -5 29 -8 0 37 -5 10 12

Trend in Nifty
CAGR in INR terms: 8.6% | CAGR in USD terms:
3.4%

10,531

10,863

12,168

13,982
6,135

4,624

5,905

6,304

8,283

7,946

8,186
CY10

CY11

CY12

CY13

CY14

CY15

CY16

CY17

CY18

CY19

CY20
Annual return in INR (%) terms Annual return in USD (%) terms

A Decade of Triumphs and Trials | January 2021 9 June 2020


Midcaps outperform large-caps; small-caps lag behind the most
Midcaps outperform large-caps during the decade

Nifty-50 rebased Nifty Midcap-100 rebased Nifty Smallcap-100 rebased


250
235
200
228
173
150

100

50
Dec-10

Dec-11

Dec-12

Dec-13

Dec-14

Dec-15

Dec-16

Dec-17

Dec-18

Dec-19

Dec-20
Jun-11

Jun-12

Jun-13

Jun-14

Jun-15

Jun-16

Jun-17

Jun-18

Jun-19

Jun-20
After underperforming in the last two years, mid-caps bounced back in CY20

Nifty-50 YoY (%) Nifty Midcap-100 YoY (%)


56
47
39
28 31 29
19 22
18 15
12
7 6 7
3 3

-5 -4 -4
-15
-25
-31
CY10 CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20

A Decade of Triumphs and Trials | January 2021 10 June 2020


IT, Consumer performed well; Cyclicals lost the most
Sectoral performance over the decade (%, CAGR)

13 CY10-CY20 (%, CAGR)


12 12
10 10 9 9 7
6
3 2

0 -1 -4 -4
Technology

Bank

Nifty Midcap 100

Capital Goods
Nifty-50

Telecom

Realty
Auto
Finance

Power
Nifty Smallcap 100
Healthcare

Oil & Gas


Consumer

Metal
Years of negative return over the decade; Consumer delivered only one-year of negative return in the decade under review

Years of negative return over CY11-20


6 6 6
5
4 4 4 4 4 4 4
3
2 2
Bank 1
Midcap

Tech
Realty

Telecom

Nifty-50
Auto
Power

Finance
Smallcap
Goods

Healthcare

Oil & Gas

Consumer
Metal
Cap.

100

100

A Decade of Triumphs and Trials | January 2021 11 June 2020


54
Bajaj Finance

35
Eicher Motors

35
Bajaj Finserv

33
Britannia Inds.

28
Shree Cement

28
Divi's Lab.

25
Asian Paints

24
Kotak Mah. Bank
24
Titan Co
WINNERS

24

HCL Tech
23

HUL

A Decade of Triumphs and Trials | January 2021


Top and bottom 15 Nifty performers over CY11-20 (%, CAGR)

20

HDFC Bank
19

Tech Mah
18

Maruti Suzuki
17

TCS

12
9

Nifty-50
7

Power Grid
6

M&M
CY10-CY20 (%, CAGR)

ITC
5

Hero Moto
4

Bharti Airtel
4

L&T
1

IOC
Nifty: Top winners and laggards in the decade gone by

Tata Steel
0
LAGGARDS

SBI
0

Hindalco Inds
-2

GAIL
-3

Tata Motors
-5

NTPC
-8

ONGC
-8

Coal India
June 2020
53
Astral Poly Tech

in CY20
KSK Energy Ven.

-41
50
Ajanta Pharma
Educomp Sol.

-39
46
P I Industries
Reliance Comm.

-35
46

Relaxo Footwear
GTL

-34
44

Aarti Industries
Punj Lloyd

-32
Top 25 gainers in the past decade

43

Atul

Bottom 25 laggards in the past decade


Reliance Capital

-32
38

Balkrishna Inds
Reliance Power

-32
35

Berger Paints
Opto Circuits

-30
34

Unitech
Page Industries

-30

A Decade of Triumphs and Trials | January 2021


32

Videocon Inds. SRF

-30
32

Reliance Infra. Honeywell Auto

-29
32

MMTC Natco Pharma

-29
31

Info Edg.(India)

13
Aban Offshore
-28
28

Reliance Nav. Abbott India


-28
28

Rolta India Mindtree


-28
Top 25 gainers over CY11-20 (%, CAGR)

28

HDIL Pidilite Inds.


-28
Bottom 25 laggards over CY10-20 (%, CAGR)
28

JP Power Ven. Havells India


-24
27

Bajaj Hindusthan Supreme Inds.


-24

JP Associates
27

MRF
-23

GVK Power Infra.


26

Cholaman.Inv.&Fn
-23

IOB
25

-23

Torrent Pharma.

Tata Steel BSL


-22
25

Amara Raja Batt.


BSE 200 (ex-Nifty): Winners and laggards in the decade gone by

Central Bank
-21
25

Whirlpool India

Union Bank (I)


-21
24

Jubilant Food.

63 Moons Tech.
-21
24

Bata India
*Source: Bloomberg, Capitaline, MOFSL. Excludes Nifty companies. Bottom 25 laggards based on BSE 200 constituents as of Dec’10. Top 25 winners based on BSE 200 constituents

June 2020
Sectoral weights in the Nifty: Fortunes for BFSI reverse
Trend in Nifty sectoral weightage (%) – Private Financials gained massively in the last decade

Weightage in Nifty (%) Change in weightage

Sector Dec’10 Dec’15 Dec’20 10-year 5-year

Automobiles 7.5 9.9 5.4 -2.1 -4.5

Banks - Private 14.5 20.7 24.7 10.2 4.1

Banks - Public 4.9 3.3 1.8 -3.1 -1.5

Insurance 0.0 0.0 1.5 1.5 1.5

NBFC 6.6 7.0 10.8 4.2 3.8

Capital Goods 8.7 4.2 2.6 -6.1 -1.6

Cement 1.9 2.8 2.2 0.3 -0.7

Consumer 6.8 10.1 11.5 4.7 1.5

Healthcare 3.7 7.3 3.6 -0.1 -3.7

Metals 8.4 1.3 2.0 -6.4 0.7

Oil & Gas 14.7 9.1 12.5* -2.2 3.3

Technology 14.3 16.3 16.3 2.0 0.0

Telecom 2.9 2.2 2.0 -0.9 -0.2

Utilities 4.5 4.1 2.1 -2.4 -2.0

Others 0.6 1.7 1.0 0.4 -0.7

Nifty 100.0 100.0 100.0

*Oil and Gas comprises Reliance Industries with 10.7% weightage. Three-fourth of RIL’s value is dominated by Telecom and Retail

A Decade of Triumphs and Trials | January 2021 14 June 2020


PSU share in Indian market at a two decade low
Indian market Cap (INR t) PSU Contribution (%)

33 33
189
31
30 CY10-20: Indian Market Cap
increased by 2.6x (10% CAGR)
28 28
27 27
26

24

22
CY00-CY20: 28.6x
(18% CAGR)
19
18
17
16 16
73 19
CY00-10: Indian Market 14
13 Cap increased by 11.1x 13
(27% CAGR)

10

7
5 6 13 17 25 36 72 31 61 53 69 70 98 100 106 152 145 156

CY00 CY01 CY02 CY03 CY04 CY05 CY06 CY07 CY08 CY09 CY10 CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20

A Decade of Triumphs and Trials | January 2021 15 June 2020


Nifty v/s Nifty Midcap 100 – Gap in m-cap is still significant
Nifty’s m-cap expanded 2.8x in the last decade, up 44% since Dec’17

Nifty (INR t) 109.3


90.0
76.0 78.9

55.5 54.5 57.1


38.4 38.7 42.7
31.3
Dec-10

Dec-11

Dec-12

Dec-13

Dec-14

Dec-15

Dec-16

Dec-17

Dec-18

Dec-19

Dec-20
M-cap of Nifty Midcap 100 still below the Dec’17 levels
6% correction from the peak
Nifty Midcap 100 (INR t) 21.9
20.6
16.7 17.0 16.7 16.1
15.9

11.0
8.2 9.0
6.9
Dec-10

Dec-11

Dec-12

Dec-13

Dec-14

Dec-15

Dec-16

Dec-17

Dec-18

Dec-19

Dec-20
A Decade of Triumphs and Trials | January 2021 16 June 2020
Top 25 companies in terms of m-cap | RIL remains the king, BFSI gains, PSUs lose
12 out of top 25 companies have remained common in the last 10-year cycle

CY10 m-cap CY15 m-cap (INR CY20 m-cap


Company Company Company CAGR (%)
(INR b) b) (INR b)
Reliance Industries 3463 TCS 4806 Reliance Industries 13,053 14
ONGC 2766 Reliance Industries 3280 TCS 10,770 17
TCS 2280 HDFC Bank 2734 HDFC Bank 7,913 22
Coal India 1986 ITC 2633 Hind. Unilever 5,624 23
Infosys 1978 Infosys 2537 Infosys 5,349 10
State Bank of India 1785 Coal India 2076 HDFC 4,606 16
NTPC 1654 ONGC 2070 Kotak Mah. Bank 3,952 28
Bharti Airtel 1361 HDFC 1993 ICICI Bank 3,692 11
ITC 1345 Sun Pharma. Inds. 1973 Bajaj Finance 3,191 62
ICICI Bank 1318 Hind. Unilever 1866 Bharti Airtel 2,779 7
Larsen & Toubro 1203 State Bank of India 1742 Asian Paints 2,652 25
Wipro 1203 ICICI Bank 1520 ITC 2,572 7
MMTC 1170 Maruti Suzuki 1394 HCL Technologies 2,567 23
BHEL 1138 Wipro 1383 State Bank of India 2,452 3
NMDC 1101 Bharti Airtel 1359 Maruti Suzuki 2,311 19
HDFC Bank 1090 Kotak Mah. Bank 1317 Wipro 2,208 6
HDFC 1066 Tata Motors 1277 Axis Bank 1,899 13
IOCL 833 HCL Technologies 1206 Larsen & Toubro 1,808 4
Tata Motors 777 NTPC 1203 Avenue Super. 1,792 NA
SAIL 754 Larsen & Toubro 1188 Nestle India 1,773 17
Adani Enterp. 714 Axis Bank 1069 Adani Green 1,646 NA
Hind. Unilever 682 IOCL 1041 UltraTech Cem. 1,525 18
Jindal Steel 666 Asian Paints 848 Sun Pharma. Inds. 1,421 11
GAIL (India) 648 Lupin 828 Bajaj Finserv 1,417 36
Cairn India 632 Bharti Infra. 812 Titan Company 1,392 24
Top 25 33613 44155 90,364 10
India 73094 100622 188,771 10
Top 25 (%) 46 44 48
Number of PSUs 10 5 1

A Decade of Triumphs and Trials | January 2021 17 June 2020


Stocks with over 1% contribution to the listed universe m-cap
Seven out of 17 stocks with over 1% contribution are from the BFSI space

% of listed m-cap
Company Sector CY10 CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20
Reliance Inds. Oil and Gas 4.7 4.3 3.9 4.1 2.9 3.3 3.3 3.8 4.9 6.2 6.9
TCS Technology 3.1 4.3 3.6 6.0 5.1 4.8 4.4 3.4 4.9 5.2 5.7
HDFC Bank Banks - Private 1.5 1.9 2.3 2.3 2.3 2.7 2.9 3.2 4.0 4.5 4.2
Hind. Unilever Consumer 0.9 1.7 1.6 1.8 1.7 1.9 1.7 2.0 2.7 2.7 3.0
Infosys Technology 2.7 3.0 1.9 2.8 2.3 2.5 2.2 1.5 2.0 2.0 2.8
HDFC NBFCs 1.5 1.8 1.8 1.8 1.8 2.0 1.9 1.8 2.3 2.7 2.4
Kotak Mah. Bank Banks - Private 0.5 0.6 0.7 0.8 1.0 1.3 1.2 1.3 1.7 2.1 2.1
ICICI Bank Banks - Private 1.8 1.5 1.9 1.8 2.1 1.5 1.4 1.3 1.6 2.2 2.0
Bajaj Fin. NBFCs 0.0 0.0 0.1 0.1 0.2 0.3 0.4 0.7 1.1 1.6 1.7
Bharti Airtel Telecom 1.9 2.4 1.7 1.9 1.4 1.4 1.2 1.4 0.9 1.5 1.5
Asian Paints Consumer 0.4 0.5 0.6 0.7 0.7 0.8 0.8 0.7 0.9 1.1 1.4
ITC Consumer 1.8 2.9 3.3 3.6 3.0 2.6 2.8 2.1 2.4 1.9 1.4
HCL Technologies Technology 0.4 0.5 0.6 1.3 1.1 1.2 1.1 0.8 0.9 1.0 1.4
State Bank of India Banks - Public 2.4 1.9 2.3 1.7 2.4 1.7 1.8 1.8 1.8 1.9 1.3
Maruti Suzuki Automobiles 0.6 0.5 0.6 0.8 1.0 1.4 1.5 1.9 1.6 1.4 1.2
Wipro Technology 1.6 1.8 1.4 2.0 1.4 1.4 1.1 0.9 1.0 0.9 1.2
Axis Bank Banks - Private 0.8 0.6 0.8 0.9 1.2 1.1 1.0 1.0 1.1 1.4 1.0
Total 26.7 30.2 29.4 34.2 31.7 31.9 30.7 29.6 35.7 40.2 41.1
Widening divergence: Contribution of Top 15 to the Top 100 m-cap at its peak

Contribution of Top 15 to the Top 100 m-cap (%)

53.1
52.1
50.7

50.6

49.2
48.1

47.8
47.4

46.5

45.6

44.5
Dec-10

Dec-11

Dec-12

Dec-13

Dec-14

Dec-15

Dec-16

Dec-17

Dec-18

Dec-19

Dec-20
A Decade of Triumphs and Trials | January 2021 18 June 2020
Billion dollar club: Contribution to Indian m-cap higher than CY17 peak
Indian 1.6 1.0 1.3 1.1 1.6 1.5 1.6 2.4 2.1 2.2 2.6
m-cap
(USD t)
Number of billion dollar companies % to Indian Mcap
329
300
282 276

224 228 91
212 214 91
187
164 88
150 88

86 86
85 85 85 85

83

CY10 CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20

Trend in companies with over USD10b and USD25b m-cap (number of companies)

>10 USDb >25 USDb


50 17
49 16
43 15
41 14
13
34 33 12
11
29 29 10
26
20 19 7 7
6
CY10

CY11

CY12

CY13

CY14

CY15

CY16

CY17

CY18

CY19

CY20
CY10

CY11

CY12

CY13

CY14

CY15

CY16

CY17

CY18

CY19

CY20

A Decade of Triumphs and Trials | January 2021 19 June 2020


Institutional flows: FIIs took the lead
FII investments in the Indian equity market stand at USD209b with only four years of outflows
Cumulative flows: USD209b

CY93-00: USD11.9b CY01-10: USD90.2b CY11-20: USD107.1b

29.3

24.5

23.4
20.0
17.8

17.6

16.2

14.2
10.8

3.3

2.9

7.7
0.8

2.2

1.2

3.1

1.6

1.7

1.5

2.7

0.7

6.7

8.6

8.1

-4.6
-0.2

-0.5
-12.2
CY93

CY94

CY95

CY96

CY97

CY98

CY99

CY00

CY01

CY02

CY03

CY04

CY05

CY06

CY07

CY08

CY09

CY10

CY11

CY12

CY13

CY14

CY15

CY16

CY17

CY18

CY19

CY20
DIIs have invested USD51b till date, with MFs being the major contributor post CY15. The same tapered off in CY20

Cumulative flows: USD51.3b

CY01-10: USD27.8b CY11-20: USD23.7b


16.9

15.9
14.0
10.2

5.3

6.0
0.1

3.1

3.7

5.4

5.3

5.9

-4.9

-4.9
-0.2

-1.1

-0.6

-0.3

-4.7

-10.9

-13.0
CY00

CY01

CY02

CY03

CY04

CY05

CY06

CY07

CY08

CY09

CY10

CY11

CY12

CY13

CY14

CY15

CY16

CY17

CY18

CY19

CY20
A Decade of Triumphs and Trials | January 2021 20 June 2020
Domestic MFs | Equity AUMs making new highs
AUM rises by 4.6x as against Nifty’s rise of 2.3x in the last 10 years
Equity Incl. ELSS & Index AUM (INR t) Nifty Index
13,982
AUM CAGR 16% 12,168
Nifty CAGR 9% 10,531 10,863 9.5
8,283 8,186 7.9 8.1
7,946 7.7
6,135 5,905 6,304
4,624
4.7
4.1

3.2
2.1 1.9
1.6 1.8

CY10 CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20

Total net inflows for the MF industry

Total Net Inflows (INR t) Equity % to total inflows

75 83
62
51
39 38
17 19
4
-25 -32

0.2 0.6 0.3 0.7 1.8 2.9 2.4 1.5 2.0 1.8

-0.9

CY10 CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20

A Decade of Triumphs and Trials | January 2021 21 June 2020


Institutional ownership increases by 700bp over the last decade
Institutional ownership (FII and DII) in Indian equities has increased in the last decade, while promoter and public ownership has declined

Promoter (%) FIIs (%) DII (%) Public / Others (%)

16.7 16.6 16.8 16.1 15.8 16.2 17.0 16.5 16.1 14.4 14.6
10.1 10.6 10.5 10.4 10.4 11.5 11.9 12.5 13.5 14.2 14.2
17.5 17.2 19.1 21.5 22.3 21.0 20.3 19.9 21.5 20.4
20.3

55.7 55.6 53.5 52.0 51.5 51.3 50.9 51.1 50.1 49.9 50.7

Dec 10 Dec 11 Dec 12 Dec 13 Dec 14 Dec 15 Dec 16 Dec 17 Dec-18 Dec-19 Sep-20

FII Proportion of Free Float (%) DII Proportion of Free Float (%)
46.0 28.9
28.4
44.9
27.1
43.2
25.6
41.2 41.3 41.4
23.9 42.9
39.6
24.1 40.6 40.6
22.8 23.6
22.6
38.7
21.6 21.5
Dec 10

Dec 11

Dec 12

Dec 13

Dec 14

Dec 15

Dec 16

Dec 17

Sep-20
Dec-18

Dec-19
A Decade of Triumphs and Trials | January 2021 22 June 2020
Fund raising | Second best year after a blockbuster CY17
Fund mobilization in public markets (INR b)
Year IPOs FPOs IDRs OFS QIPs Total equity
CY10 373 316 24.9 237 951
CY11 61 81 35 176
CY12 70 221 52 343
CY13 16 70 221 84 391
CY14 15 5 47 321 388
CY15 139 355 189 683
CY16 270 125 48 443
CY17 760 207 598 1565
CY18 335 131 165 631
CY19 178 263 352 793
CY20 460 215 805 1480

Equity raising through IPOs and FPOs (INR b) Equity raising through QIPs (INR b) Equity raising through OFS (INR b)

IPOs FPOs No of companies QIPs No of companies OFS No of companies


0
169 35
355
166 56
94 805
316
71 63 68 263
46 42 23
25 37 49 0 215
19
34 30 221 221
760 207
40
0 598 165 125
0 26 25 13
460 17 14 9 9 13
13 8
373 11 35211 131
0 335 0 9 321
70 270 237
81 178 189
0
61 70 5 139 35 52 84 48 47
16 15

CY12

CY13

CY14

CY15

CY16

CY17

CY18

CY19

CY20
CY10
CY11
CY12
CY13
CY14
CY15
CY16
CY17
CY18
CY19
CY20
CY10
CY11
CY12
CY13
CY14
CY15
CY16
CY17
CY18
CY19
CY20

A Decade of Triumphs and Trials | January 2021 23 June 2020


Market volumes grew by 33% CAGR over the last decade
Market volumes have seen a 33% CAGR increase over CY11-20

84 90 90 92 91 92 94 95 96 97 97

16 Total Daily Avg Volumes (INR B) Cash Volumes % to Total Volumes

CAGR of 33%

20,040
10 10
8 9
8
6

13,030
5

9,476
3 3
1,194

1,441

1,361

1,638

2,163

2,754

3,666

6,081
4

CY10 CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20
F&O volumes as percentage of total volumes

Ratio of FII to DII volumes has fallen

FII:DII volumes

2.6 2.6
2.5
2.3 2.2 2.2
2.0

Average of 2.1x 1.7


1.5 1.6 1.6

CY10 CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20

A Decade of Triumphs and Trials | January 2021 24 June 2020


Retail participation touching new highs in recent times

Non Institution % to Cash Volume


80

71

65

65

53

Average: 46%
50

35

28

20
Dec-10

Dec-11

Dec-12

Dec-13

Dec-14

Dec-15

Dec-16

Dec-17

Dec-18

Dec-19

Dec-20
A Decade of Triumphs and Trials | January 2021 25 June 2020
Valuation trajectory; Nifty trades in a 13-25x P/E band
Market at record high, valuations above historical averages

Nifty Nifty P/E (x)


16,000 28.0
CY10-20: Nifty CAGR: 8.6% | Average P/E: 18.8x 25.1 13,982
13,000 24.0
22.3
21.4
10,000 20.0

7,000 16.0

4,000 13.3 12.0


Dec-10

Dec-11

Dec-12

Dec-13

Dec-14

Dec-15

Dec-16

Dec-17

Dec-18

Dec-19

Dec-20
Jun-11

Jun-12

Jun-13

Jun-14

Jun-15

Jun-16

Jun-17

Jun-18

Jun-19

Jun-20
12-month forward Nifty P/B (x) 12-month forward Nifty RoE (%)

3.5 17.5

3.0 16.0
3.0

10-year average: 14.1


14.5 10-year average:
2.5 2.6x
14.0%
13.0
2.0
11.5

1.5 10.0
Dec-10

Dec-11

Dec-12

Dec-13

Dec-14

Dec-15

Dec-16

Dec-17

Dec-18

Dec-19

Dec-20

Dec-10

Dec-11

Dec-12

Dec-13

Dec-14

Dec-15

Dec-16

Dec-17

Dec-18

Dec-19

Dec-20
A Decade of Triumphs and Trials | January 2021 26 June 2020
M-cap-to-GDP ratio – 2020 saw a decade high and low
M-cap-to-GDP ratio (%)

Estimated 5% decline in FY21


GFC: Peak of 149% in Dec’07 nominal GDP growth rate

Lowest since the


103
GFC 98
95

88
82 83 83
81 79 79

71
Average of 65% for the period 69
64 66

56
52 55
45
42

26
26 23
FY00

FY01

FY02

FY03

FY04

FY05

FY06

FY07

FY08

FY09

FY10

FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21E
A Decade of Triumphs and Trials | January 2021 27 June 2020
Earnings at a glance
Earnings and returns go hand in hand

A Decade of Triumphs and Trials | January 2021 28 June 2020


Earnings and returns go hand in hand
Nifty EPS (INR) - Index earnings and index prices are two sides of the same coin

FY01-FY21 CAGR:
Nifty Index: 13%
Nifty EPS: 10%
FY11-21E CAGR:
Nifty Index: 9.1% 516
Nifty EPS: 5.1%
483
467
451
426
415
406
397
369
315 348
FY01-11 CAGR:
Nifty Index: 17.7%
Nifty EPS: 15.8% 281
251 247
236

184
169

131
73
92
78
FY01

FY02

FY03

FY04

FY05

FY06

FY07

FY08

FY09

FY10

FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21E
A Decade of Triumphs and Trials | January 2021 29 June 2020
Corporate profitability at a two decade low
Corporate Profit to GDP (%)

7.8
7.3

6.5
6.3 6.3

5.4 5.5

4.8 Average of 4.4%


4.7
4.3 4.3

3.7 3.6
3.2 3.1
3.0 2.9

2.1 2.2
1.9 1.8
FY00

FY01

FY02

FY03

FY04

FY05

FY06

FY07

FY08

FY09

FY10

FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20E
Note: Corporate profit compiled from Capitaline for available listed + unlisted companies; FY20 earnings from few unlisted companies are yet to be added,
even though it may not change aggregates meaningfully

A Decade of Triumphs and Trials | January 2021 30 June 2020


Earnings growth for the MOFSL universe has been modest over the decade
Sales (INR b) PAT (INR b)
26,339

33,829

37,997

42,084

42,697

39,763

44,135

49,932

59,660

59,513

55,020

2,674

3,105

3,218

3,501

3,622

3,749

4,259

4,497

4,868

4,606

5,283
FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21E

FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21E
EBIDTA margin excluding OMC and Finance companies (%) Net debt-to-equity (x)
0.46
20.9 0.42
0.39 0.40
20.3 0.37 0.36
Average: 0.36x 0.34 0.35 0.36
19.2 19.2 19.2
Average: 19% 19.1 0.27
18.3 18.3 18.3 18.2 18.2 0.22
FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21E

FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21E
A Decade of Triumphs and Trials | January 2021 31 June 2020
Contribution of select defensives has increased
Private Financials,Consumer and Tech (PAT,INRb) % Share to MOFSL Univ. 2,319
2,080
1,870
45
1,519 1,585 44
1,415
1,293
1,143 38 38
941 36 36 35
766
608 33
29

23 25

FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21E

Defensive Domestic Cyclicals Global Cyclicals

32 32 27 29
38 37 35 39 38
44 43

34 31 32 41 39
35 31 31 33
31 32

31 34 37 33 30 32 32
26 25 28 28
FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21E
A Decade of Triumphs and Trials | January 2021 32 June 2020
Stark divergence in intra-sector performance (FY11-21E)
Eicher Hero Moto HDFC Bank SBI Bajaj Finance Shriram Transport
34.4 22.8 21.8
61.9

22.0
9.8 34.3

7.0 3.6
3.6 7.9
3.0

PAT CAGR (%) Mcap CAGR (%) PAT CAGR (%) Mcap CAGR (%) PAT CAGR (%) Mcap CAGR (%)

HUL ITC Shree Cement ACC Divis Lab Sun Pharma


24.7 27.5
28.7 28.1
17.0
14.3
12.0 12.1
9.7
6.4
2.3 4.2

PAT CAGR (%) Mcap CAGR (%) PAT CAGR (%) Mcap CAGR (%) PAT CAGR (%) Mcap CAGR (%)

JSW Steel Tata Steel TCS Wipro Power Grid Corp. Coal India
16.5 16.3
16.9
14.2
13.8 7.7
1.2
6.8 6.5
2.2

-1.1 -9.1
PAT CAGR (%) Mcap CAGR (%) PAT CAGR (%) Mcap CAGR (%) PAT CAGR (%) Mcap CAGR (%)

A Decade of Triumphs and Trials | January 2021 33 June 2020


Macro overview
The 21st Century Thus Far: Two decades, Two Different Stories

A Decade of Triumphs and Trials | January 2021 34 June 2020


Summary of India’s economy in the first two decades of the 21st century
2000s decade 2010s decade

34.5

31.2

23.1
20.1

14.5 15.1
12.9
11.2
8.8
7.0 7.2 7.7
6.9 6.3 6.7
5.2

2.1
0.5

Real GDP^ Real Real HH investments^ Total debt^ HH savings* Total Fiscal deficit* CAD*
consumption^@ investments^$ investments*&

^ Average CAGR during the decades * Average % of GDP during the decades
@ Personal + Government $ Excluding ‘errors & omissions (E&O)’ & Including ‘E&O’; FY20 is our estimate
Total debt is our estimate compiled from all institutional sources for the non-financial sector Source: CSO, RBI, CEIC,
MoFSL

A Decade of Triumphs and Trials | January 2021 35 June 2020


Per capita GDP has scaled up by 4.7x in the last two decades

Per Capita GDP (USD)

2,139
FY10-20: Rise by 1.9x; 6.4% CAGR

2,045
2,019
FY00-FY20 : Rise by

1,768
4.7x; 8% CAGR

1,641
1,610
1,496

1,486
1,481
1,415
1,149
FY00-10: Rise by 2.5x; 9.6% CAGR

1,073

1,041
841
743
652
567
488
458

466
459
FY00

FY01

FY02

FY03

FY04

FY05

FY06

FY07

FY08

FY09

FY10

FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20
A Decade of Triumphs and Trials | January 2021 36 June 2020
Share of consumption* and investments in GDP over the past two decades (%)

(% of GDP)
Consumption* Investments

24.3 24.2 24.8 26.8 32.8 34.7 35.7 38.1 34.3 36.5 36.5 39.0 38.7 34.2 32.2
33.8 33.5 32.1 32.0

77.2 77.4 75.8 73.8 70.4


70.1 69.2 68.0 67.2 68.6 69.1 67.5 67.3 67.1 67.9 68.6 69.4 69.6 69.8

FY01 FY02 FY03 FY04 FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19

* Personal + Government Data for Gross capital formation is not yet available for FY20
Note: Numbers add up to more than 100% because it doesn't include net exports and discrepancies . Source: CSO, CEIC, MoFSL

A Decade of Triumphs and Trials | January 2021 37 June 2020


India posted its first current account surplus in 13 years in 4QFY20
Current account balance (% of GDP)
4.0

1.0

-2.0

-5.0

-8.0
2QFY09

4QFY09

2QFY10

4QFY10

2QFY11

4QFY11

2QFY12

4QFY12

2QFY13

4QFY13

2QFY14

4QFY14

2QFY15

4QFY15

2QFY16

4QFY16

2QFY17

4QFY17

2QFY18

4QFY18

2QFY19

4QFY19

2QFY20

4QFY20

2QFY21
Exports (USD B) Imports (USD B)

330
314

313
310
306

304
300

276
262
251

201
370

489

491

450

448

381

384

466

514

474

259
FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21*
(*Apr-Dec'20 )

A Decade of Triumphs and Trials | January 2021 38 June 2020


Tax-to-GDP ratio at decade low
Net Tax-GDP (%)
8.8
8.2
7.9
7.3 7.3 7.5 7.3
7.2 7.3 7.2 7.2
6.9 7.0 6.9
6.9 6.7
6.6
6.3 6.3
5.7
FY01

FY02

FY03

FY04

FY05

FY06

FY07

FY08

FY09

FY10

FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20
Fiscal Deficit (% of GDP)
6.5
6.0 6.0 5.9
5.7
5.5
5.2
4.8 4.9
4.5 4.6
4.3 4.1
3.9 4.0 3.9
3.3 3.5 3.4 3.4
2.5
FY00

FY01

FY02

FY03

FY04

FY05

FY06

FY07

FY08

FY09

FY10

FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20
A Decade of Triumphs and Trials | January 2021 39 June 2020
Strong capital inflows led to record high foreign exchange reserves
Forex Reserves (USD) Cumulative flows
of USD168b
581
Cumulative flows of USD108b
413
478
305 425
342 360 370
294 292 304

FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21*
(*As on 25th
Dec'20)

Surge in India’s forex reserves in CY20 at record high v/s other EMs

Change in forex reserves in CY20* USD b (ls) % (rs)


25.7

19.0
117
13.0
87
6.7 7.4
5.1
3.4 2.7
1.6
(0.2) 35
(2.4) 17 28 28 29

(1) (1) 4
2

Taiwan
Malaysia

Thailand
Brazil

Korea

Russia

China
Indonesia
S Africa

Philippines

India
54 356 105 134 105 436 583 253 513 3,310 575

*Up to Nov’ 20 Source: International Monetary Fund (IMF), RBI, CEIC, MoFSL

A Decade of Triumphs and Trials | January 2021 40 June 2020


Interest rates at decade low, a major boost for the coming decade
10 year G-Sec
10.9

8.8
8.4 8.2 8.4 8.3
7.8 7.9 7.9 7.8 7.7
7.6
7.1 7.3 7.0
6.9 6.9 6.7
6.2 6.0
5.4
FY01

FY02

FY03

FY04

FY05

FY06

FY07

FY08

FY09

FY10

FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21*
(*Average up to 31st Dec'20) (%, yearly average)

Repo rate
8.5
8.0
7.5 7.5
6.8 6.8
6.3 6.0 6.3

4.4 4.0

FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21*
(*As on 31st Dec'20)

A Decade of Triumphs and Trials | January 2021 41 June 2020


USD/INR: First decade was stable, second decade saw significant depreciation

78.0
USD/INR

73.1

68.0

Currency depreciated
by 63% during the
58.0
decade

Currency was quite


46.7 stable in last decade
48.0 44.7

38.0
Dec'00

Dec'01

Dec'02

Dec'03

Dec'04

Dec'05

Dec'06

Dec'07

Dec'08

Dec'09

Dec'10

Dec'11

Dec'12

Dec'13

Dec'14

Dec'15

Dec'16

Dec'17

Dec'18

Dec'19

Dec'20
A Decade of Triumphs and Trials | January 2021 42 June 2020
Oil (WTI): Journey from over 100 to negative territory
150

Geopolitical tensions in the


Strait of Hormuz raise prices to
above USD100/bbl

100
OPEC led supply cuts pushes prices to
above USD70/bbl in 2018

50

US shale oil production leads to a fall in WTI from above


USD 100/bbl to below USD 30/bbl
0

COVID-led demand destruction leads


to oil prices falling to a negative
USD37/bbl

-50
Dec'10

Dec'11

Dec'12

Dec'13

Dec'14

Dec'15

Dec'16

Dec'17

Dec'18

Dec'19

Dec'20
Jun'11

Jun'12

Jun'13

Jun'14

Jun'15

Jun'16

Jun'17

Jun'18

Jun'19

Jun'20
A Decade of Triumphs and Trials | January 2021 43 June 2020
Credit growth ends CY11-20 at an almost five decade low

Credit growth YoY (%)

40% 37%

30%

Credit growth has fallen to 5.7% YoY – lows that


were last seen post demonetization

20%

10% Credit growth fell to 13% in Sep'09


from 37% YoY in Mar’06 13%
6.1%

0%
Dec'00

Dec'01

Dec'02

Dec'03

Dec'04

Dec'05

Dec'06

Dec'07

Dec'08

Dec'09

Dec'10

Dec'11

Dec'12

Dec'13

Dec'14

Dec'15

Dec'16

Dec'17

Dec'18

Dec'19

Dec'20
A Decade of Triumphs and Trials | January 2021 44 June 2020
A Decade of Triumphs and Trials | January 2021 45 June 2020
KEY RESEARCH REPORTS OF 2020

A Decade of Triumphs and Trials | January 2021 June 2020


KEY RESEARCH REPORTS OF 2020

A Decade of Triumphs and Trials | January 2021 June 2020


Explanation of Investment Rating
Investment Rating Expected return (over 12-month)
BUY >=15%
SELL < - 10%
NEUTRAL > - 10 % to 15%
UNDER REVIEW Rating may undergo a change
NOT RATED We have forward looking estimates for the stock but we refrain from assigning recommendation

*In case the recommendation given by the Research Analyst is inconsistent with the investment rating legend for a continuous period of 30 days,the Research Analyst shall within following 30 days take appropriate
measures to make the recommendation consistent with the investment rating legend.
Disclosures:
The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations).
Motilal Oswal Financial Services Ltd. (MOFSL) is a SEBI Registered Research Analyst having registration no. INH000000412. MOFSL, the Research Entity (RE) as defined in the Regulations, is engaged in the business of
providing Stock broking services, Investment Advisory Services, Depository participant services & distribution of various financial products. MOFSL is a subsidiary company of Passionate Investment Management Pvt. Ltd..
(PIMPL). MOFSL is a listed public company, the details in respect of which are available on www.motilaloswal.com. MOFSL (erstwhile Motilal Oswal Securities Limited - MOSL) is registered with the Securities & Exchange
Board of India (SEBI) and is a registered Trading Member with National Stock Exchange of India Ltd. (NSE) and Bombay Stock Exchange Limited (BSE), Multi Commodity Exchange of India Limited (MCX) and National
Commodity & Derivatives Exchange Limited (NCDEX) for its stock broking activities & is Depository participant with Central Depository Services Limited (CDSL) National Securities Depository Limited (NSDL),NERL,
COMRIS and CCRL and is member of Association of Mutual Funds of India (AMFI) for distribution of financial products and Insurance Regulatory & Development Authority of India (IRDA) as Corporate Agent for insurance
products. Details of associate entities of Motilal Oswal Financial Services Limited are available on the website at http://onlinereports.motilaloswal.com/Dormant/documents/Associate%20Details.pdf

Details of pending Enquiry Proceedings of Motilal Oswal Financial Services Limited are available on the website at https://galaxy.motilaloswal.com/ResearchAnalyst/PublishViewLitigation.aspx

MOFSL, it’s associates, Research Analyst or their relative may have any financial interest in the subject company. MOFSL and/or its associates and/or Research Analyst may have actual/beneficial ownership of 1% or more
securities in the past 12 months. MOFSL and its associate company(ies), their directors and Research Analyst and their relatives may; (a) from time to time, have a long or short position in, act as principal in, and buy or sell
the securities or derivatives thereof of companies mentioned herein. (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial
instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related
information and opinions.; however the same shall have no bearing whatsoever on the specific recommendations made by the analyst(s), as the recommendations made by the analyst(s) are completely independent of the
views of the associates of MOFSL even though there might exist an inherent conflict of interest in some of the stocks mentioned in the research report. Research Analyst may have served as director/officer, etc. in the
subject company in the past 12 months. MOFSL and/or its associates may have received any compensation from the subject company in the past 12 months.
In the past 12 months, MOFSL or any of its associates may have:
a) managed or co-managed public offering of securities from subject company of this research report,
b) received compensation for investment banking or merchant banking or brokerage services from subject company of this research report,
c) received compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company of this research report.
d) Subject Company may have been a client of MOFSL or its associates in the past 12 months.
MOFSL and it’s associates have not received any compensation or other benefits from the subject company or third party in connection with the research report. To enhance transparency, MOFSL has incorporated a
Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. MOFSL and / or its affiliates do and seek to do business including investment
banking with companies covered in its research reports. As a result, the recipients of this report should be aware that MOFSL may have a potential conflict of interest that may affect the objectivity of this report.
Compensation of Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. Above disclosures include beneficial holdings lying in demat account of MOFSL
which are opened for proprietary investments only. While calculating beneficial holdings, It does not consider demat accounts which are opened in name of MOFSL for other purposes (i.e holding client securities, collaterals,
error trades etc.). MOFSL also earns DP income from clients which are not considered in above disclosures.

June 2020
Terms & Conditions:
This report has been prepared by MOFSL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential and may not be altered in any way, transmitted
to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of MOFSL. The report is based on the facts, figures and information that are
considered true, correct, reliable and accurate. The intent of this report is not recommendatory in nature. The information is obtained from publicly available media or other sources believed to be reliable. Such information
has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without
notice. The report is prepared solely for informational purpose and does not constitute an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments for the clients. Though
disseminated to all the customers simultaneously, not all customers may receive this report at the same time. MOFSL will not treat recipients as customers by virtue of their receiving this report.
Analyst Certification
The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly
or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report.

Disclosure of Interest Statement Companies where there is interest


 Analyst ownership of the stock No
A graph of daily closing prices of securities is available at www.nseindia.com, www.bseindia.com. Research Analyst views on Subject Company may vary based on Fundamental research and Technical Research.
Proprietary trading desk of MOFSL or its associates maintains arm’s length distance with Research Team as all the activities are segregated from MOFSL research activity and therefore it can have an independent view
with regards to subject company for which Research Team have expressed their views.

Regional Disclosures (outside India)


This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation
or which would subject MOFSL & its group companies to registration or licensing requirements within such jurisdictions.

For Hong Kong:


This report is distributed in Hong Kong by Motilal Oswal capital Markets (Hong Kong) Private Limited, a licensed corporation (CE AYY-301) licensed and regulated by the Hong Kong Securities and Futures Commission
(SFC) pursuant to the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) “SFO”. As per SEBI (Research Analyst Regulations) 2014 Motilal Oswal Financial Services Limited(SEBI Reg No.
INH000000412) has an agreement with Motilal Oswal capital Markets (Hong Kong) Private Limited for distribution of research report in Hong Kong. This report is intended for distribution only to “Professional Investors” as
defined in Part I of Schedule 1 to SFO. Any investment or investment activity to which this document relates is only available to professional investor and will be engaged only with professional investors.” Nothing here is an
offer or solicitation of these securities, products and services in any jurisdiction where their offer or sale is not qualified or exempt from registration. The Indian Analyst(s) who compile this report is/are not located in Hong
Kong & are not conducting Research Analysis in Hong Kong.

For U.S:
Motilal Oswal Financial Services Limited (MOFSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States. In
addition MOFSL is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the
United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by MOFSL, including the products and services described herein are not available to or
intended for U.S. persons. This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major
institutional investors"). This document must not be acted on or relied on by persons who are not major institutional investors. Any investment or investment activity to which this document relates is only available to major
institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the
"Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S., MOFSL has entered into a chaperoning
agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International Private Limited. ("MOSIPL"). Any business interaction pursuant to this report will have to be executed within the provisions of this
chaperoning agreement.

The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer, MOSIPL, and
therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account.

June 2020
For Singapore
In Singapore, this report is being distributed by Motilal Oswal Capital Markets Singapore Pte Ltd (“MOCMSPL”) (Co.Reg. NO. 201129401Z) which is a holder of a capital markets services license and an exempt financial
adviser in Singapore,
as per the approved agreement under Paragraph 9 of Third Schedule of Securities and Futures Act (CAP 289) and Paragraph 11 of First Schedule of Financial Advisors Act (CAP 110) provided to MOCMSPL by Monetary
Authority of Singapore. Persons in Singapore should contact MOCMSPL in respect of any matter arising from, or in connection with this report/publication/communication. This report is distributed solely to persons who
qualify as “Institutional Investors”, of which some of whom may consist of "accredited" institutional investors as defined in section 4A(1) of the Securities and Futures Act, Chapter 289 of Singapore (“the SFA”). Accordingly,
if a Singapore person is not or ceases to be such an institutional investor, such Singapore Person must immediately discontinue any use of this Report and inform MOCMSPL.

Disclaimer: The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any
other person or to the media or reproduced in any form, without prior written consent. This report and information herein is solely for informational purpose and may not be used or considered as an offer document or
solicitation of offer to buy or sell or subscribe for securities or other financial instruments. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is
suitable or appropriate to your specific circumstances. The securities discussed and opinions expressed in this report may not be suitable for all investors, who must make their own investment decisions, based on their own
investment objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this document should make such
investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own
advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. Certain transactions -including those involving futures, options, another
derivative products as well as non-investment grade securities - involve substantial risk and are not suitable for all investors. No representation or warranty, express or implied, is made as to the accuracy, completeness or
fairness of the information and opinions contained in this document. The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as
endorsement of the views expressed in the report. This information is subject to change without any prior notice. The Company reserves the right to make modifications and alternations to this statement as may be required
from time to time without any prior approval. MOFSL, its associates, their directors and the employees may from time to time, effect or have effected an own account transaction in, or deal as principal or agent in or for the
securities mentioned in this document. They may perform or seek to perform investment banking or other services for, or solicit investment banking or other business from, any company referred to in this report. Each of
these entities functions as a separate, distinct and independent of each other. The recipient should take this into account before interpreting the document. This report has been prepared on the basis of information that is
already available in publicly accessible media or developed through analysis of MOFSL. The views expressed are those of the analyst, and the Company may or may not subscribe to all the views expressed therein. This
document is being supplied to you solely for your information and may not be reproduced, redistributed or passed on, directly or indirectly, to any other person or published, copied, in whole or in part, for any purpose. This
report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or
use would be contrary to law, regulation or which would subject MOFSL to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all
jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. Neither the Firm, not its directors, employees,
agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that may arise from or in connection with the use of the
information. The person accessing this information specifically agrees to exempt MOFSL or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOFSL
or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOFSL or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered
by the person accessing this information due to any errors and delays.

Registered Office Address: Motilal Oswal Tower, Rahimtullah Sayani Road, Opposite Parel ST Depot, Prabhadevi, Mumbai-400025; Tel No.: 022 71934200/ 022-71934263; Website www.motilaloswal.com.
CIN No.: L67190MH2005PLC153397.Correspondence Office Address: Palm Spring Centre, 2nd Floor, Palm Court Complex, New Link Road, Malad(West), Mumbai- 400 064. Tel No: 022 7188 1000.
Registration Nos.: Motilal Oswal Financial Services Limited (MOFSL)*: INZ000158836(BSE/NSE/MCX/NCDEX); CDSL and NSDL: IN-DP-16-2015; Research Analyst: INH000000412. AMFI: ARN - 146822; Investment
Adviser: INA000007100; Insurance Corporate Agent: CA0579 ;PMS:INP000006712. Motilal Oswal Asset Management Company Ltd. (MOAMC): PMS (Registration No.: INP000000670); PMS and Mutual Funds are offered
through MOAMC which is group company of MOFSL. Motilal Oswal Wealth Management Ltd. (MOWML): PMS (Registration No.: INP000004409) is offered through MOWML, which is a group company of MOFSL. Motilal
Oswal Financial Services Limited is a distributor of Mutual Funds, PMS, Fixed Deposit, Bond, NCDs,Insurance Products and IPOs.Real Estate is offered through Motilal Oswal Real Estate Investment Advisors II Pvt. Ltd.
which is a group company of MOFSL. Private Equity is offered through Motilal Oswal Private Equity Investment Advisors Pvt. Ltd which is a group company of MOFSL. Research & Advisory services is backed by proper
research. Please read the Risk Disclosure Document prescribed by the Stock Exchanges carefully before investing. There is no assurance or guarantee of the returns. Investment in securities market is subject to market
risk, read all the related documents carefully before investing. Details of Compliance Officer: Name: Neeraj Agarwal, Email ID: na@motilaloswal.com, Contact No.:022-71881085.

* MOSL has been amalgamated with Motilal Oswal Financial Services Limited (MOFSL) w.e.f August 21, 2018 pursuant to order dated July 30, 2018 issued by Hon'ble National Company Law Tribunal, Mumbai Bench.

June 2020

You might also like